期刊文献+

浅蓝霉素产生菌海洋异壁放线菌WH1-2216-6遗传操作体系的建立 被引量:3

Development of a genetic modification system for caerulomycin producer Actinoalloteichus sp.WH1-2216-6
原文传递
导出
摘要 【目的】建立二联吡啶类抗生素浅蓝霉素的产生菌海洋异壁放线菌Actinoalloteichus sp.WH1-2216-6的遗传操作体系,以便对浅蓝霉素的相关生物合成基因进行体内敲除和基因回补等遗传操作。【方法】以整合型质粒pSET152为外源DNA,探索和优化了异壁放线菌WH1-2216-6菌株与大肠杆菌进行接合转移实验的方法和条件,以此为基础,利用PCR-targeting系统在体外构建了一个浅蓝霉素二羟基苯甲酸甲酯AMP连接酶基因敲除的cosmid质粒pCSG2104,并在优化后的条件下通过接合转移将其转入异壁放线菌WH1-2216-6野生型菌株。【结果】获得了异壁放线菌WH1-2216-6菌株的浅蓝霉素二羟基苯甲酸甲酯AMP连接酶基因缺失的双交换突变株,发酵结果显示该突变株失去了产生浅蓝霉素A和浅蓝霉素D的能力。【结论】高浓度的MgSO4对大肠杆菌与异壁放线菌的接合转移有促进作用,介导了异壁放线菌WH1-2216-6菌株的遗传操作体系的成功建立,为进一步研究浅蓝霉素的生物合成基因和对浅蓝霉素结构进行组合生物合成改造奠定了基础,同时也为其他类似放线菌的遗传操作体系的建立提供了借鉴和参考。 [Objective] In order to enable the caerulomyicn biosynthetic study by in vivo gene disruptions,it is crucial to develop a genetic modification system for the producer Actinoalloteichus sp.WH1-2216-6.[Methods] The spore germination timing and the concentration of MgSO4 in the medium were investigated for the optimal conjugal transfer of exotic pSET152 DNA into Actinoalloteichus sp.WH1-2216-6.Using the PCR-targeting system,we disrupted a putative caerulomycin 2,3-dihydroxybenzoate-AMP ligase gene by "in-frame deletion" in E.coli,to afford the cosmid pCSG2104,which was then transferred into Actinoalloteichus sp.WH1-2216-6 by conjugation under optimized conditions.[Results] The putative caerulomycin 2,3-dihydroxybenzoate-AMP ligase in Actinoalloteichus sp.WH1-2216-6 was successfully disrupted by in-frame replacement with the aac3IV gene cassette.The resulting mutant strain was unable to produce caerulomycins.[Conclusion] The presence of high concentration of MgSO4 in the medium can promote the conjugation efficiency between E.coli and Actinoalloteichus sp.WH1-2216-6 and lead to the successful development of a genetic modification system for Actinoalloteichus sp.WH1-2216-6,enabling the functional characterization of caerulomycin biosynthetic genes in vivo.A positive example was provided for other Actinobacteria recalcitrant to genetic modification.
出处 《微生物学报》 CAS CSCD 北大核心 2011年第8期1032-1041,共10页 Acta Microbiologica Sinica
基金 国家自然科学基金(31070045) 国家重点基础研究发展计划(973计划)项目(2010CB833805) 中国科学院知识创新工程重要方向项目(KZCX2-YW-G-065,KZCX2-YW-JC202,LYQY200805) 中国科学院百人计划项目(08SL111002)~~
关键词 异壁放线菌 遗传体系 浅蓝霉素 生物合成 二羟基苯甲酸甲酯AMP连接酶 actinoalloteichus genetic manipulation system caerulomycin biosynthesis 2 3-dihydroxybenzoate-AMP ligase
  • 相关文献

参考文献26

  • 1Funk A, Divekar PV. Caerulomycin, a new antibiotic from Streptomyces caeruleus Baldacci: I. Production,isolattion, assay, and biological properties. Canadian Journal of Microbiology, 1959, 5(4) : 317-321.
  • 2Divekar PV, Read G, Vining LC. Caerulomycin, a new antibiotic from Streptomyces caeruleus Baldacci. Ⅱ. Structure. Canadian Journal of Chemistry, 1967, 45 (11) : 1215-1223.
  • 3Chandran RR, Sankaran R, Divekar PV. Phytotoxic properties of Caerulomycin and some of its derivatives. Journal of Antibiotics, 1968, 21 (3) : 243.
  • 4McInnes AG, Smith DG, Wright JLC, Vining LC. Caerulomycins B and C, new 2,2' -dipyridyl derivatives from Streptomyces caeruleus. Canadian Journal of Chemistry, 1977, 55(24) : 4159-4165.
  • 5McInnes AG, Smith DG, Walter JA, Wright JLC, Vining LC, Arsenauh GP. Caerulomycin D, a novel glycosidic derivative of 3,4-dihydroxy-2,2' -dipyridyl 6aldoxime from Streptomyces caeruleus. Canadian Journal of Chemistry, 1978, 56( 13 ) : 1836-1842.
  • 6Vining LC, Mclnnes AG, McCulloch AW, Smith DG, Walter JA. The biosynthesis of Caerulomyeins in Streptomyces caeruleus. Isolation of a new Caerulomycin and incorporation of picolinic acid and glycerol into Caerulomycin A. Canadian Journal of Chemistry, 1988, 66(1) : 191-194.
  • 7Chatterjee DK, Raether W, Iyer N, Ganguli BN. Caerulomycin, an antifungal antibiotic with marked in vitro and in vivo activity against Entamoeba histolytica. Zeitschrift fur Parasitenkunde-Parasitology Research, 1984, 70(5) : 569-573.
  • 8Singla AK, Agrewala JN, Vohra RM, Jolly RS. Use of bipyridine compound 'caerulomycin A' derivatives and analogs thereof as immunosuppressive agents. USA: US 2007/0078167 A1, April. 5, 2007.
  • 9Zhou H, Xie XK, Tang Y. Engineering natural products using combinatorial biosynthesis and biocatalysis. Current Opinion in Biotechnology, 2008, 19 (6) : 590-596.
  • 10白林泉,邓子新.微生物次级代谢产物生物合成基因簇与药物创新[J].中国抗生素杂志,2006,31(2):80-86. 被引量:35

二级参考文献68

共引文献99

同被引文献19

  • 1LIVERMORE D M. Future Directions with Daptomycin [J]. Journal of Antimicrobial Chemotherapy, 2008, 62(Suppl. 3): 41-49.
  • 2MIAO V, COEFFET LeGal M F, BRIAN P, et al. Daptomycin Biosynthesis in Streptomyces roseosporus : Cloning and Analysis of the Gene Cluster and Revision of Peptide Stereochemistry [J]. Microbiology, 2005, 151 (5): 1507-1523.
  • 3PHORNPHISUTTHIMAS S, SUDTACHAT N, BUNYOO C, et al. Development of an Intergeneric Conjugal Transfer System for Rimocidin-Producing Streptomyces rimosus[J]. Letters in Applied Microbiology, 2010, 50 (2010): 530-536.
  • 4DU L, LIU R H, YING L, et al. An Efficient Intergeneric Conjugation of DNA from Escherichia coli to Mycelia of the Lincomycin-Producer Streptomyces lincolnensis[J]. International Journal of Molecular Sciences, 2012, 13: 4797-4806.
  • 5FEDORYSHYN M, WELLE E, BECHTHOLD A, et al. Functional Expression of the Cre Recombinase in Actinomyce- tes [J]. Applied Microbiology and Biotechnology, 2008, 78: 1065-1070.
  • 6FLETT F, MERSINIAS V, SMITH C P. High Efficiency Intergeneric Conjugal Transfer of Plasmid DNA from Esche richia coli to Methyl DNA-Restricting Streptomyces[J]. FEMS Microbiology Letters, 1997, 155:223-229.
  • 7BALTZ R H. Genetic Manipulation of Antibiotic-Producing Streptomyces [J]. Trends in Microbiology, 1998(6): 76-83.
  • 8VOEiKOVA T A. The Conjugal Transfer of Plasmids from Escherichia coli to Various Strains of the Order Actinomyc- etales [J]. Genetika, 1999, 35: 1626-1633.
  • 9杨旻,陶美凤.雷帕霉素产生菌吸水链霉菌NRRL5491接合转移系统的建立[J].华中农业大学学报,2007,26(5):637-641. 被引量:7
  • 10刘炳辉,曹远银,闫建芳,齐小辉,程浩,黄盼盼,刘秋.聚酮类化合物生物合成基因簇与药物筛选[J].生物技术通报,2008,24(4):30-33. 被引量:8

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部